## Abstract A major problem in head and neck cancer surgery is the high rate of local relapse (LR). In at least 25% of the surgically treated head and neck squamous cell carcinoma (HNSCC) patients, a genetically defined preneoplastic lesion, also known as βfield,β can be detected in the surgical ma
Prognostic implications of loss of heterozygosity at 8p21 and 9p21 in head and neck squamous cell carcinoma
β Scribed by Steven W. Coon; Adnan T. Savera; Richard J. Zarbo; Michael S. Benninger; Gary A. Chase; Benjamin A. Rybicki; Daniel L. Van Dyke
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- French
- Weight
- 118 KB
- Volume
- 111
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Loss of heterozygosity (LOH) in chromosomal regions that harbor tumor suppressor genes from tumor tissue may lead to decreased survival time in cancer patients with squamous cell carcinoma of the head and neck (HNSCC). We studied 8 regions frequently lost in HNSCC in 150 patients having a primary diagnosis of HNSCC. Tumor and normal tissue DNA were genotyped for microsatellite repeat markers in 8 unlinked chromosomal regions. The association between LOH and death from HNSCC was investigated, weighted by number of informative markers per region and adjusted for age at diagnosis, selfβreported race, tumor stage and current smoking status. LOH at 3 chromosomal regions were independently associated with reduced survival. A greater risk for cancer mortality was observed for LOH at chromosomal regions 3p24.3βp14.3 (p = 0.02), 8p21.3βp11.21 (p = 0.02) and 9p24.2βp21.2 (p = 0.03). In these regions, LOH at one or more markers was observed in 66.9%, 43.3% and 60.6% of patients, respectively. Survival times were significantly shorter for those with LOH at marker NEFL on 8p21.2 (relative risk = 6.15; p = 0.0002) and at D9S126 on 9p21.2 (relative risk = 5.96; p = 0.0003). Our results indicate that LOH at several chromosomal sites may offer additional independent prognostic information beyond traditional indicators such as tumor stage and age. Β© 2004 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Abstract ## Background __IGF2__ and __H19__ are reciprocal imprinted genes with paternal and maternal monoallelic expression, respectively. This is interesting, because __IGF2__ is known as a growth factor, and __H19__ encodes a RNA with putative tumor suppressor action. Furthermore, __IGF2__ a
To identify the putative tumor-suppressor gene (TSG) involved in transitional-cell carcinoma (TCC) of the urinary bladder, we undertook an allelotyping analysis in 48 cases of TCC. Relatively high percentages of allelic loss were found in 2p (5 of 23, 21.7%), 8p (9 of 21, 42.9%), 9p (4 of 20, 20.0%)
## Abstract The __p16__^INK4a^ gene, localized within chromosome 9p21, has been identified as a cyclinβdependent kinase inhibitor and may negatively regulate the cell cycle acting as a tumor suppressor. Genetic alterations involving the 9p21 region are common in human cancers. A consecutive series
Background. Head and neck squamous cell carcinomas (HNSCC) are treated by surgery or radiotherapy. Tumor cell death-related markers, such as p21 and Ki-67, may predict response to therapy and improve treatment choice. We evaluated and compared the effect of their coexpression between patients treate
In this study, 105 non-papillary renal cell carcinomas (RCCs) have been examined for allelic loss at the chromosome 8p12-21.1, 9p21, and 14q24.2-qter regions, each by two highly polymorphic microsatellites. Loss of heterozygosity (LOH) was detected at both chromosome 8p and 9p in 33 per cent of the